MERIT MEDICAL SYSTEMS

Merit Medical Launches the TEMNO Elite™ Soft Tissue Biopsy System

27 Sep 2022 09:25:00 By Nasdaq GlobeNewswire

Merit Medical Launches the Prelude Roadster™ Guide Sheath

12 Sep 2022 09:25:00 By Nasdaq GlobeNewswire

Merit Medical Launches SafeGuard Focus Cool™ Compression Device

08 Aug 2022 09:25:00 By Nasdaq GlobeNewswire

Merit Medical Reports Results for Quarter Ended June 30, 2022

27 Jul 2022 16:15:01 By Nasdaq GlobeNewswire

Merit Medical Launches Smallest and Shortest Configuration of Elation® Pulmonary Balloon Dilator to Help Meet Critical Patient Need

20 Jul 2022 11:00:00 By Nasdaq GlobeNewswire

Merit Medical Systems to Announce Second Quarter Results on July 27, 2022

14 Jul 2022 09:25:00 By Nasdaq GlobeNewswire

First Patient Enrolled in the Streamlined Localization (STREAMLoc) Registry Study Using SCOUT® at Biopsy in Canada

13 Jul 2022 09:25:00 By Nasdaq GlobeNewswire

New SCOUT® Mini Reflector Provides Physicians with a Compact Design for Greater Utility

07 Jul 2022 11:00:00 By Nasdaq GlobeNewswire

First Patient Enrolled in Merit Medical’s WRAPSODY™ Registry (WRAP) Study

05 Jul 2022 12:02:12 By Nasdaq GlobeNewswire

Merit Medical Celebrates Completion of Xeriscape Landscaping Project

29 Jun 2022 17:30:00 By Nasdaq GlobeNewswire

Merit Medical Reports Results for Quarter Ended March 31, 2022

27 Apr 2022 16:05:01 By Nasdaq GlobeNewswire

Merit Medical Announces Chief Operating Officer Transition

21 Apr 2022 16:05:01 By Nasdaq GlobeNewswire

Merit Medical’s Chief Legal Officer and Corporate Secretary, Brian Lloyd, Receives Corporate Counsel Award from Utah Business Magazine

21 Apr 2022 09:25:00 By Nasdaq GlobeNewswire

Merit Medical Announces Launch of ReSolve® Thoracostomy Tray

18 Apr 2022 09:25:00 By Nasdaq GlobeNewswire

Merit Medical Systems to Announce First Quarter Results on April 27, 2022

13 Apr 2022 13:28:59 By Nasdaq GlobeNewswire

Merit Medical Receives FDA Clearance for SCOUT Bx™ Delivery System

11 Apr 2022 09:25:00 By Nasdaq GlobeNewswire

Merit Medical Receives FDA “Breakthrough Device Designation” for Embosphere® Microspheres for Use in Genicular Artery Embolization for Symptomatic Knee Osteoarthritis

07 Mar 2022 09:25:00 By Nasdaq GlobeNewswire

Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2021, Issues FY 2022 Guidance

24 Feb 2022 16:05:03 By Nasdaq GlobeNewswire

Merit Medical Systems to Announce Fourth Quarter and Year End 2021 Results on February 24, 2022

17 Jan 2022 16:55:00 By Nasdaq GlobeNewswire

Merit Medical Announces Agreement in Principle to Settle Class Action Litigation

23 Nov 2021 09:25:00 By Nasdaq GlobeNewswire